Astellas Pharma Inc. Wins Japan Approval for New Transplant Drug

TOKYO, July 17 (Reuters) - Astellas Pharma Inc said on Thursday it had won approval to sell a new version of its key transplant drug in Japan, the second major region where it has gained approval although it is facing delays in the United States.